Navigation Links
New Data From REALISTIC Study Showed Cimzia® (certolizumab pegol) Provided Rapid and Sustained Efficacy, Over 28 Weeks, in a Broad Population of Patients With Moderate to Severe Rheumatoid Arthritis (RA) Including Those Who Discontinued Prior Anti-T
Date:11/7/2011

ible with hypersensitivity reactions, including angioedema, dyspnea, hypotension, rash, serum sickness, and urticaria, have been reported rarely following CIMZIA administration. If such reactions occur, discontinue further administration of CIMZIA and institute appropriate therapy.

Hepatitis B Reactivation

Use of TNF blockers, including CIMZIA, may increase the risk of reactivation of hepatitis B virus (HBV) in patients who are chronic carriers of this virus. Some cases have been fatal. Evaluate patients at risk for HBV infection for prior evidence of HBV infection before initiating CIMZIA therapy. Exercise caution in prescribing CIMZIA for patients identified as carriers of HBV, with careful evaluation and monitoring prior to and during treatment. In patients who develop HBV reactivation, discontinue CIMZIA and initiate effective anti-viral therapy with appropriate supportive treatment.

Neurologic Reactions

Use of TNF blockers, including CIMZIA, has been associated with rare cases of new onset or exacerbation of clinical symptoms and/or radiographic evidence of central nervous system demyelinating disease, including multiple sclerosis, and with peripheral demyelinating disease, including Guillain-Barre syndrome. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA. Exercise caution in considering the use of CIMZIA in patients with these disorders.

Hematologic Reactions

Rare reports of pancytopenia, including aplastic anemia, have been reported with TNF blockers. Medically significant cytopenia (e.g., leukopenia, pancytopenia, thrombocytopenia) has been infrequently reported with CIMZIA. Advise all patients to seek immediate medical attention if they develop signs and symptoms suggestive of blood dyscrasias or infection (e.g., persiste
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
(Date:8/28/2015)... Ill. , Aug. 28, 2015 ... Companies, Inc. (Nasdaq: PDCO ), is now ... previously announced acquisition of Patterson Medical by Madison ... will retain its name for a transition period ... of rehabilitation and sports medicine products.  With the ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Bevacizumab Market 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3
... March 24, 2011 Reportlinker.com announces that a ... catalogue: Triple Analysis: Colorectal Cancer, ... http://www.reportlinker.com/p0284811/Triple-Analysis-Colorectal-Cancer-Leukemia-and-Pancreatic-Cancer.html This triple analysis focuses ... Leukemia and Pancreatic Cancer. Each of these three ...
... 24, 2011 Reportlinker.com announces that a new ... Process Analytical Technologies for Pharmaceuticals: ... The global market for process analytical ... million in 2010. This market is expected to ...
Cached Medicine Technology:Reportlinker Adds Triple Analysis: Colorectal Cancer, Leukemia and Pancreatic Cancer 2Reportlinker Adds Triple Analysis: Colorectal Cancer, Leukemia and Pancreatic Cancer 3Reportlinker Adds Triple Analysis: Colorectal Cancer, Leukemia and Pancreatic Cancer 4Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 2Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 3Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 4Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 5Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 6Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 7Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 8Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 9Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 10Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 11Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 12Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 13Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 14Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets 15
(Date:8/31/2015)... ... August 31, 2015 , ... NSF International, ... the water, food, health sciences and consumer goods industries, has recognized Clean Water ... iron filtration media, Pro-OX Manganese Dioxide. , Developed by a team of scientists ...
(Date:8/31/2015)... ... August 31, 2015 , ... GenHart Software, LLC, a rising ... to help small businesses operate as efficiently and cost effectively as possible, with a ... impact in their first year of operation – and the Charleston business community is ...
(Date:8/30/2015)... ... August 31, 2015 , ... The acknowledgement from Caribbean ... by TripAdvisor earlier in 2015. The island of Providenciales itself received a TripAdvisor ... The Venetian on Grace Bay is offering a special promotion for newlyweds and honeymooners ...
(Date:8/30/2015)... ... 31, 2015 , ... This month, top rated New York ... living facilities and nursing homes protect their residents from neglect and improper care ... at the company, security systems don’t just protect; they also help monitor patients ...
(Date:8/30/2015)... ... 30, 2015 , ... InHealth Media ( http://www.inhealthmedia.com ) announced ... Director for InHealth Media. Mr. Spector comes with a wide array of ... on-air television, producing shows, on air-radio and media relations. , Brian joins ...
Breaking Medicine News(10 mins):Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 2Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 3Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 3Health News:Grace Bay Beach Named a Top Beach Destination for Weddings 2Health News:Total Security Announces Security Systems Tips for New York Assisted Living Facilities and Nursing Homes 2Health News:Total Security Announces Security Systems Tips for New York Assisted Living Facilities and Nursing Homes 3Health News:InHealth Media Appoints New Global Communications Director 2
... in Honor of National Family Caregiver Month, NAPLES, ... Month, AgingCare.com wants to make a deserving caregiver,s life,a ... $2,000 of,free housecleaning., To enter the contest, family ... sweet moment they,ve shared with their,loved one, some upbeat ...
... MONICA, Calif., Nov. 13 Cord Blood,America, Inc. ... stem,cell preservation company ( http://www.cordblood-america.com ) focused on,bringing ... families nationwide and,internationally, said today that a letter ... on the Company,s website. The letter explains,some of ...
... Comedy Writer, Alan Zweibel, Keynote Speaker, NEW ... tickets,for Turn the Corner Foundation,s, http://www.turnthecorner.org, ... The big event, Unmask a,Cure, will be held ... in,New York City. Celebrities and prominent physicians involved ...
... Hospital, a state-run,psychiatric hospital in the Catawba Valley ... comfort systems to make the buildings,more energy efficient ... hospital anticipates $1 million in savings over five ... associated with the new,heating, ventilating and air conditioning ...
... launch Moxatag(TM), the first and only FDA-approved ... of 2009, GERMANTOWN, Md., Nov. 13 , ... closed a $100 million financing transaction with ... -- MiddleBrook repurchased the Keflex(R) assets for approximately $11.0 ...
... Sports and,Nutritional Supplements developer and manufacturer ... that the company,s primary operating,subsidiary, Interactive Nutrition ... exclusive contract for manufacturing and distribution of ... Sigurdur Arnason and,companies owned by Sigurdur Arnason. ...
Cached Medicine News:Health News:People Caring for Aging Parents Can Win $2,000 of Free Housecleaning 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 3Health News:Turn the Corner Honors Andy Abrahams Wilson, Director of Under Our Skin, for His Dedication in the Fight Against Lyme Disease 2Health News:Turn the Corner Honors Andy Abrahams Wilson, Director of Under Our Skin, for His Dedication in the Fight Against Lyme Disease 3Health News:Virginia Mental Health Hospital Improves Patient Comfort, Receives Award for Energy-Saving Renovations 2Health News:Virginia Mental Health Hospital Improves Patient Comfort, Receives Award for Energy-Saving Renovations 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 8Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 9Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 10Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results 11Health News:Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: